A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma

BACKGROUND: The current management guidelines recommend that patients with borderline resectable pancreatic adenocarcinoma (BRPC) should initially receive neoadjuvant chemotherapy. The addition of advanced radiation therapy modalities, including stereotactic body radiation therapy (SBRT) and intraop...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Paiella, Salvatore, Malleo, Giuseppe, Simoni, Nicola, Micera, Renato, Guariglia, Stefania, Cavedon, Carlo, Marchegiani, Giovanni, Esposito, Alessandro, Landoni, Luca, Casetti, Luca, Tuveri, Massimiliano, Milella, Michele, Secchettin, Erica, Manzini, Gessica, Bovo, Chiara, De Pastena, Matteo, Fontana, Martina, Salvia, Roberto, Mazzarotto, Renzo, Bassi, Claudio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2021
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7885611/
https://ncbi.nlm.nih.gov/pubmed/33593311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-07877-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia